Zimbabwe has rejected a substantial US health deal valued at 367 million US dollars (£272m) spanning five years because of Washington's insistence on confidential biological samples.
This move came to light following a government memo from December was disclosed, revealing that Head of State Emmerson Mnangagwa believed the agreement was "unbalanced".
An official spokesman later explained that the US was seeking health data for research and commercial purposes but was not willing to share the resulting advantages from any future medical innovations.
"We are forced to start the difficult and regrettable process of scaling back our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had donated over $1.9bn in health funding to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has called for continued talks to find a deal acceptable to all parties so the nation's critical HIV treatment initiative can be sustained.
Broader Implications
This development comes after a similar situation in neighbouring Kenya, where a high court blocked a similar health funding agreement after concerns were filed about the safety of citizens' medical information.
After resuming the presidency recently, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
The agency had overseen assistance for the American government, but Trump claimed its expenditure was "inefficient" and his government was seeking direct bilateral agreements to enhance openness and accountability.
According to reports, Sixteen nations in Africa have so far signed these new health pacts, representing over $18.3bn in committed funds.
Details of the Declined Deal
The funds for Zimbabwe would have gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this partnership could have provided extraordinary advantages for the people of Zimbabwe, especially the 1.2 million presently on HIV treatment via American-funded programmes," the Ambassador commented.
However, official spokesman Nick Mangwana said the proposed deal was "unequal".
"Our nation was requested to provide its genetic material and health information for a long time, without any corresponding promise of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that provided information," Mangwana explained.
"Put simply, our nation would supply the basic resources for medical research without any assurance that the final treatments would be accessible to our population should a future pandemic arise."
Sovereignty and International Frameworks
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were upending frameworks previously set up through the international organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing system created to manage potential pandemics.
"This framework is intended to guarantee that when a nation contributes its data, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the capability to create them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We welcome continued dialogue with our US partners on how subsequent collaboration could be arranged in a manner that honours the independence and interests of each country."
Medical Community Response
Medical experts stated it understood the government's concerns, but suggested that negotiations must proceed since a large portion of the nation's Aids initiatives relied on international support.
"In cases where specific concerns exist, such as those involving information security or agreement terms, these can often be resolved via technical clarification and mutually agreed protections," it commented.
The halted deal emphasises the ongoing challenges between accepting vital international aid and protecting national sovereignty in an ever more data-driven world.